Alyeska Investment Group, L.P. Abb Vie Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $106 Million - $122 Million	731,371 New	731,371 $117 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $23.9 Million - $36.2 Million	-370,536 Reduced 65.7%	193,474 $14.7 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $14 Million - $17.5 Million	-193,545 Reduced 25.55%	564,010 $49.9 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $46.5 Million - $55.9 Million	738,261 Added 3826.38%	757,555 $57.4 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $1.35 Million - $1.72 Million	19,294	19,294 $1.71 Million

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.